Long Island Gastrointestinal Research Group

Great Neck, New York 11023

0 studies enrolling now · 21 studies all time

What they study most

Autoimmune Diseases, Celiac, Celiac Disease, Chronic Constipation, Chronic Idiopathic Constipation, Chronic Pain, Diabetic Gastroparesis, Diarrhea Predominant Irritable Bowel Syndrome, Digestive System Disease, Diverticulitis, Enteric Hyperoxaluria, Gastrointestinal Disease

Studies at this site

• Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients — Completed
• Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe Gastroparesis — Completed
• A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis — Completed
• Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain — Completed
• Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria — Stopped early
• Prevention of Recurrence of Diverticulitis — Completed
• Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone — Completed
• Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury — Completed
• Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone — Completed
• A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) — Status unconfirmed
• An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation — Completed
• Long-term Open-Label Safety Study to Evaluate EN3409 — Completed
• Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM — Completed
• Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects — Completed
• Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects — Completed
• Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation — Completed
• Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic Constipation — Stopped early
• A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC) — Completed
• Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome — Completed
• Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) — Completed
• A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel Syndrome — Completed